These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 23306701
41. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway. Sun L, Guo Z, Sun J, Li J, Dong Z, Zhang Y, Chen J, Kan Q, Yu Z. Biomed Pharmacother; 2018 Nov; 107():168-176. PubMed ID: 30086463 [Abstract] [Full Text] [Related]
42. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Lang Q, Ling C. Biochem Biophys Res Commun; 2012 Sep 21; 426(2):247-52. PubMed ID: 22940133 [Abstract] [Full Text] [Related]
43. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation. Jiang J, Zhang Y, Guo Y, Yu C, Chen M, Li Z, Tian S, Sun C. Oncotarget; 2015 Mar 20; 6(8):6359-72. PubMed ID: 25849943 [Abstract] [Full Text] [Related]
44. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S, Wang L, Yao B, Liu Q, Guo C. Biomed Pharmacother; 2019 Sep 20; 117():109055. PubMed ID: 31176165 [Abstract] [Full Text] [Related]
45. 125I suppressed the Warburg effect viaregulating miR-338/PFKL axis in hepatocellular carcinoma. Zheng J, Luo J, Zeng H, Guo L, Shao G. Biomed Pharmacother; 2019 Nov 20; 119():109402. PubMed ID: 31514072 [Abstract] [Full Text] [Related]
47. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Chen G, Shi Y, Liu M, Sun J. Cell Death Dis; 2018 Feb 07; 9(2):175. PubMed ID: 29415990 [Abstract] [Full Text] [Related]
50. Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3. Lu J, Tang L, Xu Y, Ge K, Huang J, Gu M, Zhong J, Huang Q. J Cell Biochem; 2018 Nov 07; 119(11):9229-9238. PubMed ID: 29953647 [Abstract] [Full Text] [Related]
51. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H, Li B, Yang J. Biomed Pharmacother; 2018 Nov 07; 107():754-762. PubMed ID: 30142536 [Abstract] [Full Text] [Related]
52. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS. World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352 [Abstract] [Full Text] [Related]
58. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma. Xie BH, He X, Hua RX, Zhang B, Tan GS, Xiong SQ, Liu LS, Chen W, Yang JY, Wang XN, Li HP. Cancer Biomark; 2016 May 01; 16(3):405-13. PubMed ID: 27062697 [Abstract] [Full Text] [Related]
59. MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway. Wu Y, Zhang Y, Wang F, Ni Q, Li M. Biochem Biophys Res Commun; 2020 Oct 22; 531(4):480-489. PubMed ID: 32807493 [Abstract] [Full Text] [Related]